Core Laboratories Nv Stock Performance
| CLB Stock | USD 18.88 0.85 4.71% |
On a scale of 0 to 100, Core Laboratories holds a performance score of 17. The firm shows a Beta (market volatility) of 2.4, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Core Laboratories will likely underperform. Please check Core Laboratories' value at risk, expected short fall, and the relationship between the treynor ratio and downside variance , to make a quick decision on whether Core Laboratories' price patterns will revert.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Core Laboratories NV are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain essential indicators, Core Laboratories sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 4.71 | Five Day Return 16.26 | Year To Date Return 11.39 | Ten Year Return (80.57) | All Time Return 529.33 |
Forward Dividend Yield 0.0022 | Payout Ratio | Last Split Factor 2:1 | Forward Dividend Rate 0.04 | Dividend Date 2025-11-24 |
1 | Core Laboratories Expected to Beat Earnings Estimates Should You Buy | 10/15/2025 |
2 | Core Laboratories Margin Gains Reinforce Bullish Narrative Despite Slowing Revenue Growth | 10/24/2025 |
3 | Core Laboratories Skyrockets After Beating Estimates in Q3 | 10/28/2025 |
4 | Core Laboratories Inc Q3 2025 Earnings Call Highlights Strong Revenue Growth and ... - Yahoo Finance | 11/04/2025 |
5 | Why Core Laboratories Inc. stock remains resilient - 2025 Performance Recap AI Driven Stock Reports - newser.com | 11/10/2025 |
6 | Core Laboratories Down 15.6 percent Since Last Earnings Report Can It Rebound | 11/21/2025 |
| Core Laboratories dividend paid on 24th of November 2025 | 11/24/2025 |
7 | Acquisition by Harvey Klingensmith of 8069 shares of Core Laboratories subject to Rule 16b-3 | 11/28/2025 |
8 | Disposition of 864 shares by Sow Teo of Core Laboratories subject to Rule 16b-3 | 12/01/2025 |
9 | Fisher Asset Management LLC Sells 143,838 Shares of Core Laboratories Inc. CLB - MarketBeat | 12/04/2025 |
10 | Disposition of 180722 shares by Lawrence Bruno of Core Laboratories subject to Rule 16b-3 | 12/31/2025 |
11 | Is Core Laboratories Inc.s Recent Stock Performance Tethered To Its Strong Fundamentals | 01/06/2026 |
| Begin Period Cash Flow | 15.1 M | |
| Total Cashflows From Investing Activities | -6.4 M |
Core Laboratories Relative Risk vs. Return Landscape
If you would invest 1,094 in Core Laboratories NV on October 11, 2025 and sell it today you would earn a total of 794.00 from holding Core Laboratories NV or generate 72.58% return on investment over 90 days. Core Laboratories NV is generating 0.9897% of daily returns assuming volatility of 4.5427% on return distribution over 90 days investment horizon. In other words, 40% of stocks are less volatile than Core, and above 81% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Core Laboratories Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Core Laboratories' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Core Laboratories NV, and traders can use it to determine the average amount a Core Laboratories' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2179
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CLB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Core Laboratories is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Core Laboratories by adding it to a well-diversified portfolio.
Core Laboratories Fundamentals Growth
Core Stock prices reflect investors' perceptions of the future prospects and financial health of Core Laboratories, and Core Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Core Stock performance.
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0497 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 981.01 M | ||||
| Shares Outstanding | 46.56 M | ||||
| Price To Earning | 101.74 X | ||||
| Price To Book | 3.09 X | ||||
| Price To Sales | 1.63 X | ||||
| Revenue | 523.85 M | ||||
| Gross Profit | 103.23 M | ||||
| EBITDA | 73.27 M | ||||
| Net Income | 32.15 M | ||||
| Cash And Equivalents | 19.16 M | ||||
| Cash Per Share | 0.29 X | ||||
| Total Debt | 180.14 M | ||||
| Debt To Equity | 1.29 % | ||||
| Current Ratio | 2.23 X | ||||
| Book Value Per Share | 5.89 X | ||||
| Cash Flow From Operations | 56.39 M | ||||
| Earnings Per Share | 0.68 X | ||||
| Market Capitalization | 845.5 M | ||||
| Total Asset | 590.41 M | ||||
| Retained Earnings | 150.28 M | ||||
| Working Capital | 129.02 M | ||||
| Current Asset | 238.55 M | ||||
| Current Liabilities | 120.76 M | ||||
About Core Laboratories Performance
By analyzing Core Laboratories' fundamental ratios, stakeholders can gain valuable insights into Core Laboratories' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Core Laboratories has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Core Laboratories has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 44.81 | 27.79 | |
| Return On Tangible Assets | 0.06 | 0.06 | |
| Return On Capital Employed | 0.11 | 0.20 | |
| Return On Assets | 0.05 | 0.05 | |
| Return On Equity | 0.12 | 0.14 |
Things to note about Core Laboratories performance evaluation
Checking the ongoing alerts about Core Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Core Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Core Laboratories appears to be risky and price may revert if volatility continues | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| On 24th of November 2025 Core Laboratories paid $ 0.01 per share dividend to its current shareholders | |
| Latest headline from simplywall.st: Is Core Laboratories Inc.s Recent Stock Performance Tethered To Its Strong Fundamentals |
- Analyzing Core Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Core Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Core Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Core Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Core Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Core Laboratories' stock. These opinions can provide insight into Core Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Core Stock analysis
When running Core Laboratories' price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |